Pay in 4 interest-free payments of $6.31 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Semaglutide holds FDA approval under multiple brand names (Ozempic, Wegovy, Rybelsus) for type 2 diabetes and chronic weight management, backed by some of the largest cardiometabolic outcome trials conducted on any incretin therapy, including documented effects on HbA1c, body weight, and cardiovascular risk markers
Semaglutide is a 31-amino acid peptide with a molecular weight of approximately 4,113.58 daltons
A novel GLP-1 and FGF21 dual agonist has therapeutic potential for diabetes and non-alcoholic steatohepatitis
The most common side effects include: While Semaglutide and Tirzepatide are generally well tolerated and safe to use, they cannot be taken if you have any of the following: During your first visit, well talk through your weight loss goals and what has or hasnt worked foryou in the past
.png?w=1280&max-h=720&fit=crop&auto=format)
